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Background and PurposeᄏTemporal changes in the quality of life (QOL) and the underlying 
factors after epilepsy surgery might be specific to Korea, where social stigma toward patients 
with epilepsy is still pronounced. 
MethodsᄏThe seizure characteristics, number of antiepileptic drugs (AEDs), and the presence 
of stigma, anxiety, and depression were assessed before and after surgery (at 6 months and ar-
ound 2 years) in 32 surgery patients and 32 nonsurgery patients. The QOL was compared be-
tween these groups using the Epilepsy Surgery Inventory-55 questionnaire. The factors affect-
ing QOL were also evaluated. 
ResultsᄏThe scores in the mental, physical, and role-functioning domains were significantly 
higher at 6 months (all p<0.01) and around 2 years (all p<0.01) than at baseline in the surgery 
group but not in the nonsurgery group. The factors related to QOL differed at the two follow-
up times, with seizure freedom being important at 6 months, and AEDs and depression being 
important at around 2 years. 
ConclusionsᄏA marked increase in QOL in our population was observed after epilepsy sur-
gery. Although the small sample limits the interpretation of the results, the QOL change in our 
surgery patients shows similar trends to those reported in Western countries. A full understand-
ing of underlying factors related to QOL might aid the development of optimal strategies for im-
proving the long-term postsurgery QOL in this population.  J Clin Neurol 2008;4:116-122
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Introduction 
 
Epilepsy is one of the most common chronic neurological 
disorders. Although recent advances in surgical techniques 
mean that intractable epileptic seizures can be managed re-
latively well, some studies have inferred that a reduction in 
seizures does not necessarily lead to an improvement in qu-
ality of life (QOL),
1 while others have found that seizure free-
dom postsurgery is associated with significant improvements 
in QOL.
2-8 The QOL can be complex and multifactorial, 
depending not only on the seizure outcome, but also on the 
patient’s psychological status and feelings of social stigma.
9-11 
The QOL of surgery patients in Asian countries, where the 
social and cultural environment can differ from their Western 
counterparts, has rarely been studied,
12 nor have the factors 
affecting QOL in these patients been investigated at different 
follow-up times.   
Therefore, this study was performed to determine the QOL 
of surgery patients and the factors related to QOL at 6 months 
and 2 years after surgery. We also compared the QOL in the 
surgery group with that in a nonsurgery control group com-
prising patients with a similar presurgery evaluation. 
 
Methods 
 
This study was approved by the Institutional Review Bo-
ard of the College of Nursing at Seoul National University. 
We collected data before surgery and at 6 months and around 
2 years (mean 23.4 months) after surgery in the surgery group. 
In the nonsurgery group, data were collected at 6 months and  
 
 
 
 
Choi-Kwon S et al. 
  www.thejcn.com 117
around 19 months (mean 19.3 months) after the initial assess-
ment. Six months after surgery was chosen as the first fol-
low-up time to avoid the compounding effect of surgery and 
to give the subjects sufficient time to adapt to their new lives. 
The second follow-up was at around 2 years after surgery in 
order to reveal the long-term effects of surgery on QOL. Writ-
ten informed consent was obtained before each interview, with 
the first interview taking place in the Epilepsy Monitoring 
Unit (EMU) at Seoul National University Hospital.   
Sixty-four patients with intractable seizure who were ad-
mitted to the EMU underwent presurgery evaluations including 
long-term monitoring. An extensive interview was also con-
ducted to evaluate the presurgery QOL and the presence of 
depression, anxiety, and stigma. The intractable patients were 
defined as those who had experienced uncontrolled seizures 
for more than 2 years despite having received appropriate 
antiepileptic drug (AED) polytherapy for more than 2 years. 
Among the 64 patients, those patients who underwent the 
same presurgery evaluation but no surgery constituted the 
control group (n=32). They did not receive surgery for one 
of the following reasons: 1) they had an ictal onset zone that 
could not be localized (n=9); 2) their ictal zone could be 
localized but was discordant with the results obtained from 
MRI, PET, or ictal Single Photon Emission Computed 
Tomography (SPECT)(n=12); 3) they were treatable with 
AEDs despite having been referred from other hospitals as 
intractable cases (n=3); or 4) they refused surgery (n=8). 
In accordance with Birbeck et al. reporting that a significant 
improvement in QOL requires seizure freedom,
13 we chose 
the absence of seizures as the end point. 
Before the interview, all the patients were assessed by 
experienced epileptologists at Seoul National University re-
garding the type, duration, and frequency of the seizures. The 
number of AEDs was also assessed. Seizure types were cate-
gorized into four groups: 1) simple partial seizures, includ-
ing aura only; 2) complex partial seizures with alteration of 
consciousness; 3) generalized seizures; and 4) other types 
of seizure, including absence seizures and myoclonic seizures. 
The interview was performed by two trained research nurses 
using a structured questionnaire that gathered demographic 
data on age, gender, level of education, marital status, cur-
rent employment status, and economic status.
14  
The Korean version of the Hospital Anxiety and Depres-
sion (HAD) scale comprising 14 items with 4-point responses 
(7 items each for anxiety and depression) was used to meas-
ure the depression and anxiety levels.
15,16 Depression or an-
xiety was considered to be present if the score was >10 in 
either the anxiety or depression inventory, with scores of 8-
10 considered indicative of borderline depression or anxiety.
15 
In statistical comparisons, those patients with borderline de-
pression or anxiety were categorized as having depression or 
anxiety. 
A three-item epilepsy stigma scale was used,
10,17 with each 
item scored as a simple yes (1) or no (0) response. The over-
all score was the sum of the positive responses (range, 0-3), 
with a higher score indicating a higher likelihood of the pa-
tient feeling stigmatized. For statistical analysis, those patients 
with nonzero scores were categorized as having stigma. 
QOL was assessed using the Epilepsy Surgery Inventory 
(ESI)-55 questionnaire, which consists of 55 items.
18 The 
ESI-55 is scored on 11 subscales (health, energy, QOL, social 
functioning, emotional functioning, cognitive functioning, 
role-emotional, role-memory, role-physical, physical func-
tion, and pain) and 3 composite scales for physical health, 
mental health, and role functioning. The questionnaire was 
translated into Korean by a professional translator. For the 
Short-Form Health Survey (SF)-36 items contained in the 
ESI-55, the official Korean translated version of the SF-36 
(with known reliability and validity) was used.
19,20 Testing 
of its reliability revealed that its internal consistency (Cron-
bach’s alpha) ranged from 0.78 to 0.90, which exceeds the 
generally accepted criterion (0.70) for adequate reliability for 
group comparisons. Test-retest reliabilities at baseline and 6 
months in the control group ranged from r=0.79 to r=0.84, 
which also exceeds the commonly used cutoff of r=0.70. 
During the clinic visits at each follow-up after the initial 
assessment, the changes in seizure characteristics (including 
seizure frequency and number of AEDs) were recorded by 
an epileptologist. The scores on the ESI-55, HAD, and stigma 
scales were also obtained for both groups. 
 
Statistics 
The data were analyzed with descriptive statistics, chi-
square test, and paired t-test for demographics and clinical 
characteristics of the subjects. ANOVA or paired t-test was 
also used for comparing QOL and the factors related to QOL 
between the groups and between the differenttime points in 
each group. 
 
Results 
 
Demographic and clinical characteristics of the 
subjects 
Fig. 1 shows the number of patients included in each part 
of the protocol. Of the 32 patients who received surgery, 3 
could not be contacted, leaving 29 patients at the 6-month 
follow-up. At the 2-year follow-up, 2 could not be contacted, 
1 had died, and 1 had developed schizophrenia, leaving 25 
patients. Of the 32 patients who did not receive surgery, 4 
could not be contacted, 2 had moved to another country, and  
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2 declined to participate in the study, leaving 24 patients at 
the 6-month follow-up. At the 19-month follow-up, 2 could 
not be reached, leaving 22 patients in the nonsurgery group. 
At the baseline, the demographic and clinical characteristics 
did not differ between the surgery and nonsurgery groups ex-
cept for the diagnosis and the type of seizure (Table 1). Ante-
rior temporal-lobe resection was performed in 22 (69%) of the 
surgery patients, and 10 (31%) received neocortical resection. 
Of the 29 patients who had received surgery, 25 (86%) were 
seizure-free, 3 (10%) had one seizure per month, and 1 (3%) 
had four seizures per month at the 6-month follow-up. At the 
2-year follow-up, 21 (84%) were seizure-free, and 2 (8%) 
and 2 (8%) had reductions in seizure frequencies of ≥75% 
and <75%, respectively. Relapse at around the 2-year follow-
up occurred in two patients (8%) who remitted at 6 months 
after surgery.   
Of the 24 patients who had not received surgery, 10 
(42%) achieved seizure freedom and 2 (8%) had a reduc-
tion in seizure frequency of >75% at the 6-month follow-
up. Of the 22 patients followed-up at 19 months, 10 (45%) 
achieved seizure freedom (Table 2). Table 2 indicates that 
AED usage had decreased at around 2 years (p<0.01) but not 
at 6 months after surgery, whereas AED usage had increased 
at around 19 months (p<0.01) in the nonsurgery group. 
 
Stigma, anxiety, and depression  
At the baseline, the presence of stigma, anxiety, and de-
pression did not differ significantly between the surgery and 
nonsurgery groups (Table 2). The number of patients with 
stigma, anxiety, or depression declined significantly (all p< 
0.01) between the baseline and at both follow-ups in the 
surgery group but not in the nonsurgery group. Moreover, 
the number of patients with stigma, anxiety, or depression was 
significantly lower in the surgery group than in the nonsur-
gery group at follow-ups at 6 months (p<0.05) and around 2 
years (p<0.01)(Table 2).  
 
Quality of life in the surgery and nonsurgery 
patients  
The QOL scores on the 11 subscales and 3 composite sc-
ales of the ESI-55 at different follow-ups are listed in Table 3. 
Table 1. Demographics and clinical characteristics of patients with
epilepsy 
Surgery  
group 
Nonsurgery 
group   
(n=32)  (n=32) 
Age (years) 30.6±9.90 31.4±9.3 
Gender    
  Male 19  (59.4) 26  (81.3) 
Education (years) 12.8±2.80 13.6±2.9 
Marital status     
  Married 20  (62.5) 21  (65.6) 
  Single 12  (37.5) 11  (34.4) 
Diagnosis    
  TLE 25  (78.1) 12  (37.5)** 
  FLE 2  (6.3)  08 (25.0) 
  PLE 1  (3.1) 2  (6.3) 
  OLE 2  (6.3) 0  (0) 
  Other 2  (6.3) 10  (31.3) 
No. of AEDs     
  0 0  (0) 2  (6.3) 
  1 11  (34.4) 10  (32.3) 
  2  05 (15.6)  09 (28.1) 
  >2 16  (50.0) 11  (34.4) 
Employed    
  Yes 18  (56.3) 22  (68.8) 
Economic status (monthly 
 income, South Korean won) 
  
  <100 million  11 (34.4) 11  (34.4) 
  100-200 million  15 (46.9)  09 (28.1) 
  >200 million  06 (18.8) 12  (37.5) 
Duration of seizures (years) 14.7±11.4 10.1±8.4 
Type of seizure     
  Simple partial  1 (3.1) 3  (9.4)* 
  Complex partial  26 (81.3) 20  (62.5) 
  Secondary generalized  05 (15.6)  09 (28.1) 
Seizure frequency    
  ≤1/month 15  (46.9) 14  (45.8) 
  >1/month 17  (53.1) 18  (54.2) 
Data are mean±SD or n (%) values. *p<0.05, **p<0.01. SD: stand-
ard deviation, AEDs: antiepileptic drugs, TLE: temporallobe epi-
lepsy, FLE: frontal-lobe epilepsy, PLE: parietal-lobe epilepsy, OLE:
occipital-lobe epilepsy 
 
Fig. 1. Flow diagram. 
32 surgery 
64 collected 
32 non-surgery 
29 with complete   
6 months follow-up 
24 with complete   
6 months follow-up 
3 unable to reach 
4 unable to reach     
2 living abroad 
2 rejected 
25 with complete   
24 months follow-up 
2  u n a b l e   t o   re a c h            
1 died 
1 developed schizophrenia 
2 unable to reach 
22 with complete   
19 months follow-up  
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The three composite scales did not differ between the two 
groups at baseline (Table 3), and they were significantly im-
proved at follow-ups at 6 months (all p<0.01) and around 2 
years (all p<0.01) relative to the baseline in the surgery group 
but not in the nonsurgery group.   
The postsurgery scores for the physical-health and role-
functioning composite measures at 6 months (p<0.01 and 
p<0.05, respectively) and around 2 years (p<0.01 and p<0.05, 
respectively) were significantly higher in the surgery group 
than in the nonsurgery group.   
Factors related to quality of life in the surgery 
group  
At the 6-month follow-up, seizure freedom (p<0.01) and 
the presence of stigma (p<0.01) and anxiety (p<0.05) were 
related to the mental-health composite measure, whereas eco-
nomic status (p<0.05) and seizure freedom (p<0.05) were 
related to the physical-health composite measure. No factors 
were related to the role-functioning composite measure. 
At the 2-year follow-up, the number of AEDs (p<0.01) and 
the presence of depression (p<0.01), anxiety (p<0.01), and 
Table 2. Changes in seizure frequency, stigma, anxiety, and depression
Surgery group  Nonsurgery group 
  Baseline 
(n=32) 
6 months 
(n=29) 
2 years 
(n=25) 
Baseline 
(n=32) 
6 months 
(n=24) 
19 months 
(n=22) 
Seizure frequency 
 reduced  by ≥75% 
25 (86.2)
‡ 
 
23 (92.0)
‡ 
 
 
12 (50.0) 
 
10 (45.4) 
 
Seizure freedom  25 (86.2)
‡ 21  (84.0)
‡   10  (41.7) 10  (45.4) 
No. of AEDs  0  0 (0)  00 (0)  08 (32.0)*
‡  02 (6.3)0  00 (0.0)0  00 (0.0)0 
 1  11  (34.4)  09 (31.0)  06 (24.0) 10  (31.3)  05 (20.8)  03 (13.6) 
 2  05 (25.6)  07 (24.1)  05 (20.0)  09 (28.1) 10  (41.7)  08 (36.4) 
 >2  16  (50.0) 13  (44.8)  06 (24.0) 11  (34.4)  09 (37.5) 11  (50.0) 
 No  15  (46.9) 24  (82.8) 24  (96.0) 16  (50.0) 14  (58.3) 13  (59.1) 
Stigma Yes  17  (53.1)  05 (17.2)**
‡  01 (4.0)**
‡ 16  (50.0) 10  (41.7)  09 (40.9) 
Anxiety No  14  (43.8) 21  (72.4)**
† 22  (88.0)**
‡ 22  (68.8) 15  (62.5) 14  (63.6) 
 Yes  18  (56.3)  08 (27.6)  03 (12.0) 10  (21.3)  09 (37.5)  08 (36.3) 
Depression No  13  (40.6) 20  (69.0)**
† 22  (88.0)**
‡ 16  (50.0) 13  (54.2) 11  (50.0) 
 Yes 19  (59.4)  09 (31.0)  03 (12.0) 16  (50.0) 11  (45.9) 11  (50.0) 
Data are n (%) values. *p<0.05, compared to baseline, **p<0.01, compared to baseline,  †p<0.05, between surgery and nonsurgery 
groups, ‡p<0.01, between surgery and nonsurgery groups. AEDs: antiepileptic drugs 
 
Table 3. Quality of life (QOL) in the surgery and nonsurgery groups
Surgery group  Nonsurgery group 
  Baseline  
(n=32) 
6 months   
(n=29) 
2 years   
(n=25) 
Baseline  
(n=32) 
6 months   
(n=24) 
19 months   
(n=22) 
Perceived health  52.0±10.1 69.2±16.7** 74.8±18.0** 53.3±18.0 59.8±17.7* 57.9±18.7 
Energy/Fatigue 40.4±15.7 62.8±17.5** 63.6±23.1** 48.2±19.8 50.4±25.0 51.1±24.5 
Overall QOL  50.0±14.4 68.8±13.0** 65.4±20.9** 55.5±14.0 61.9±13.8* 62.5±14.0 
Social functioning  59.0±19.6 83.0±20.4** 76.7±30.2* 69.4±22.4 68.3±23.6 69.0±22.8 
Emotional well-being  45.9±14.8 65.4±19.9** 66.7±22.4** 58.9±18.7 55.2±24.3 56.4±24.1 
Cognitive functioning  62.7±19.9 72.8±20.0 66.9±28.2 55.4±29.9 51.4±30.7 50.3±30.2 
Role limitations due to 
 emotional  problems 
52.8±37.4 
 
85.6±26.2** 
 
98.0±5.8** 
 
53.3±44.8 
 
67.5±44.5 
 
65.7±45.7 
 
Role limitations due to 
 memory  problems 
52.8±37.8 
 
80.8±33.4* 
 
86.4±30.9** 
 
60.0±40.8 
 
55.2±45.2 
 
54.3±44.5 
 
Role limitations due to 
 physical  problems 
45.6±33.4 
 
83.2±25.6** 
 
94.8±20.2** 
 
48.0±42.4 
 
50.4±45.2 
 
51.3±42.5 
 
Physical functioning  83.2±20.0 93.8±10.8* 95.8±14.0** 79.8±24.1 86.8±18.8 87.6±17.3 
Pain 53.2±22.8 85.2±19.8** 91.0±22.4** 61.0±26.3 71.5±23.3* 70.3±23.1 
CMH 50.0±9.60 69.2±12.0** 68.3±20.4** 56.5±14.4 58.0±18.3 56.1±16.3 
CPH 58.0±14.6 81.4±12.4**
‡  86.9±15.9**
‡  60.6±19.9 67.3±19.7 68.5±19.3 
CRF 54.3±20.9 81.4±18.0**
†  85.9±16.2**
†  55.8±29.8 60.0±31.7 59.0±32.5 
Data are mean±SD values. *p<0.05, compared to baseline, **p<0.01, compared to baseline,  †p<0.05, between surgery and non-
surgery groups,  ‡p<0.01, between surgery and nonsurgery groups. CMH: composite mental health, CPH: composite physical health,
CRF: composite role functioning 
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stigma (p<0.01) were related to the mental-health compo-
site measure. The number of AEDs (p<0.05) and stigma 
(p<0.05) were also related to the physical-health composite 
measure, whereas economic status (p<0.05), number of AEDs 
(p<0.01), seizure freedom (p<0.01), depression (p<0.01), 
and anxiety (p<0.05) were related to the role-functioning com-
posite measure.   
 
Discussion 
 
To our knowledge, this is the first investigation of how the 
QOL changes over time after epilepsy surgery as compared 
to presurgery in Korea, and which has included measure-
ment of the QOL in a control nonsurgery group. Although 
the small sample limits the interpretation of the results, our 
study also appears to indicate that the factors affecting QOL 
vary with the follow-up time after surgery. 
We collected QOL data at 6 months to avoid the possible 
confounding effect of surgery, with the results demonstrating 
that the QOL had improved even at this time after surgery.
7 
One previous study found improvement in the QOL as early 
as 3 months postsurgery,
21 whereas others found no such im-
provement.
3, 4,12,22,23 However, in our study, role functioning 
was the composite measure that had improved the most at 6 
months, which was not evident until 1 year after surgery in 
previous studies.
3,4,12,22,23 There are several possible explan-
ations for this discrepancy. Firstly, a marked increase in QOL 
at 6 months did not appear to be simply due to the passage of 
time, since the QOL in the nonsurgery group had not im-
proved relative to baseline after 6 months, even though scores 
on the pain, social-functioning, and health-perception sub-
scales had improved significantly. Rather, it might be related 
to 86% of the patients being seizure-free. However, other fac-
tors might also have been involved, since the seizure out-
come data in our study were comparable to those of the other 
studies finding no improvement in QOL until 1 year after 
surgery.
3,12 Secondly, the decrease in stigma, depression, and 
anxiety at 6 months that was evident in the surgery group but 
not in the nonsurgery group might have improved the QOL.
24 
Finally, we cannot rule out the possibility that the lower base-
line QOL in our study was due to the sociocultural environment 
being less favorable in Korea than in Western societies,
9,10,24,25 
with this influencing the marked increase in QOL at 6 months. 
We found that the improvement in QOL was not greater at 
2 years after surgery than at 6 months after surgery, which is 
not consistent with previous studies.
3,12,26,27 However, this 
might have been related to the significant improvement in 
QOL that was already present at 6 months (i.e., a ceiling 
effect). In addition, the patients might also have experienced 
more burden with the problems of normal life at 2 years, 
which would have offset any improvement in the QOL re-
sulting from the epilepsy surgery.
28 The most common ex-
pectations for surgery in our patients were obtaining employ-
ment or a better job, but they often experienced employment 
difficulties. Only three of our patients reported that they ob-
tained a better paying job at the 2-year follow-up. However, 
the QOL did not decrease to the level before surgery, in-
dicating that they had at least maintained their improved 
QOL during the 2-year postsurgery period.   
We found that some patients who were seizure-free after 
surgery were still experiencing anxiety at the 6-month and 2-
year follow-ups, which is consistent with previous studies.
21,29 
We suspect that the continuing fear of seizure recurrence in 
such patients can lower the QOL. Indeed, those patients who 
experienced anxiety had lower scores on the mental and 
physical composite QOL scales at the 6-month follow-up.   
It is interesting that depression was related to the QOL at 
the 2-year follow-up but not at the 6-month follow-up. De-
pression has been reported to be closely related to temporal-
lobe epilepsy.
30-32 Patients with depression might be inhe-
rently predisposed to depression, which could present at 2 
years after surgery. The occurrence of mood disturbance as a 
postsurgery complication is now clearly recognized.
11 Wil-
son et al. also reported that psychiatric diagnoses of anxiety 
and depression were the most frequent reasons for patient 
readmission after anterior temporal lobectomies.
28  
It is also interesting that the factors important to a high 
QOL differed between the 6-month and 2-year follow-ups. 
Although the small sample prevented us from performing a 
multivariate analysis, seizure freedom was one of important 
factors related to two of the composite QOL scales at 6 
months but not at 2 years, whereas taking more than two 
AEDs was related to all three composite QOL measures at 2 
years but not at 6 months. A negative correlation between the 
number of AEDs and the QOL has been reported previ-
ously.
33,34 We did not have information regarding the side 
effects of AEDs in our patients, but it is likely that they 
experienced difficulties taking the medications and concern 
over their long-term side effects.
35 In addition, the cost of 
AEDs might have constituted an extra burden in their lives. 
It is also plausible that they did not expect to be continuously 
medicated with more than two AEDs at 2 years after surgery, 
especially when they experienced increased seizure freedom.   
Our study was subject to some limitations. Firstly, the pre-
surgery measurements of anxiety, depression, and QOL in 
patients with epilepsy might have been affected by the pre-
sence of stress. However, the average time between data col-
lection and surgery was 70 days, and the QOL and the scores 
on the HAD scale did not differ between the surgery and 
nonsurgery groups, suggesting that the presurgery environ- 
 
 
 
 
Choi-Kwon S et al. 
  www.thejcn.com 121
ment did not affect the presurgery data.   
Secondly, sampling bias might have been present since the 
patients lost at the 2-year follow-up might have experienced 
seizures with worse characteristics and been less satisfied 
with the treatment or surgery. However, the patients who were 
not followed were all seizure-free at 6 months, making it 
likely that they withdrew after achieving seizure freedom. The 
good seizure outcome in the surgery group (86%) suggests 
that we applied very strict criteria for inclusion. However, 
the seizure reduction in our study was comparable to that 
found in previous studies.
12,23 In addition, the high rate of 
seizure freedom in the nonsurgery group might have been 
due to the number of patients referred from other hospitals 
who were found to be ineligible for surgery but treatable with 
AEDs. However, regardless of the rate of seizure freedom, 
the QOL in these patients did not improve significantly at the 
6-month follow-up. The rate of seizure freedom in the non-
surgery group was higher than that found in some previous 
studies
6,33 but consistent with other studies.
26 
Thirdly, patients with a low economic status who could not 
afford such an expensive surgical procedure (which was not 
fully covered by national or private insurance) might have 
been underrepresented. Therefore, the results obtained here 
might not be generalizable to all seizure patients. Finally, the 
two groups we studied were not perfectly matched, since one 
group qualified for the surgery and one did not, and the se-
cond follow-up time differed slightly between the two groups. 
In conclusion, the QOL in our population was markedly 
increased as early as 6 month after epilepsy surgery and was 
sustained until 2 years postsurgery, trends that are similar to 
those found in Western countries. However, the factors related 
to a better QOL differed at each follow-up, with psycholo-
gical factors being more important than freedom from sei-
zures at 2 years. The small number of patients in our study 
means that further studies with larger numbers of patients are 
required to fully clarify these factors. 
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